R.-P. Müller

884 total citations
30 papers, 624 citations indexed

About

R.-P. Müller is a scholar working on Pulmonary and Respiratory Medicine, Pathology and Forensic Medicine and Neurology. According to data from OpenAlex, R.-P. Müller has authored 30 papers receiving a total of 624 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Pulmonary and Respiratory Medicine, 8 papers in Pathology and Forensic Medicine and 6 papers in Neurology. Recurrent topics in R.-P. Müller's work include Lymphoma Diagnosis and Treatment (7 papers), Lung Cancer Treatments and Mutations (7 papers) and Glioma Diagnosis and Treatment (5 papers). R.-P. Müller is often cited by papers focused on Lymphoma Diagnosis and Treatment (7 papers), Lung Cancer Treatments and Mutations (7 papers) and Glioma Diagnosis and Treatment (5 papers). R.-P. Müller collaborates with scholars based in Germany, Switzerland and Austria. R.-P. Müller's co-authors include H Luginbühl, Herbert L. Ratcliffe, G. L. Rossi, V. Sturm, Harald Treuer, Martin Köcher, M Hoevels, Wolfgang Schlegel, Jürgen Voges and Hans Theodor Eich and has published in prestigious journals such as Radiology, British Journal of Cancer and International Journal of Radiation Oncology*Biology*Physics.

In The Last Decade

R.-P. Müller

29 papers receiving 591 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
R.-P. Müller Germany	14	256	156	133	111	110	30	624
Luca Rigobello Italy	11	102 0.4×	47 0.3×	53 0.4×	94 0.8×	450 4.1×	15	700
Philip B. Wilson United Kingdom	15	63 0.2×	82 0.5×	30 0.2×	58 0.5×	39 0.4×	20	588
Maja Walier Germany	9	89 0.3×	69 0.4×	12 0.1×	183 1.6×	64 0.6×	15	783
M Schlumberger France	11	50 0.2×	255 1.6×	54 0.4×	133 1.2×	16 0.1×	40	700
A. Sztankay Austria	12	80 0.3×	89 0.6×	99 0.7×	60 0.5×	5 0.0×	20	529
Daniel Lindsay United Kingdom	13	190 0.7×	114 0.7×	38 0.3×	37 0.3×	10 0.1×	42	473
Gabriel Rivera United States	9	156 0.6×	182 1.2×	139 1.0×	13 0.1×	67 0.6×	16	570
Yufang Zhu China	13	73 0.3×	89 0.6×	41 0.3×	31 0.3×	117 1.1×	41	518
Takakazu Sasaguri Japan	16	100 0.4×	183 1.2×	97 0.7×	126 1.1×	25 0.2×	40	777
Sladjana Andrejević Serbia	15	171 0.7×	41 0.3×	83 0.6×	41 0.4×	147 1.3×	40	618

Countries citing papers authored by R.-P. Müller

Since Specialization

Citations

This map shows the geographic impact of R.-P. Müller's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R.-P. Müller with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R.-P. Müller more than expected).

Fields of papers citing papers by R.-P. Müller

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by R.-P. Müller. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R.-P. Müller. The network helps show where R.-P. Müller may publish in the future.

Co-authorship network of co-authors of R.-P. Müller

This figure shows the co-authorship network connecting the top 25 collaborators of R.-P. Müller. A scholar is included among the top collaborators of R.-P. Müller based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with R.-P. Müller. R.-P. Müller is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Eich, Hans Theodor, Heinz Schmidberger, Boris Böll, et al.. (2013). The German evidence-based guidelines for Hodgkin’s lymphoma. Strahlentherapie und Onkologie. 189(6). 445–447. 3 indexed citations

Sasse, Stephanie, Beate Klimm, Helen Görgen, et al.. (2012). Comparing long-term toxicity and efficacy of combined modality treatment including extended- or involved-field radiotherapy in early-stage Hodgkin's lymphoma. Annals of Oncology. 23(11). 2953–2959. 25 indexed citations

Semrau, R., Sebastian Herzog, Daniel Vallböhmer, et al.. (2012). Radiotherapy in elderly patients with inoperable esophageal cancer. Strahlentherapie und Onkologie. 188(3). 226–234. 26 indexed citations

Majdoub, Faycal El, et al.. (2012). Stereotactic LINAC radiosurgery for the treatment of brainstem cavernomas. Strahlentherapie und Onkologie. 188(4). 311–318. 20 indexed citations

Semrau, R., Sebastian Herzog, Daniel Vallböhmer, et al.. (2011). Prognostic factors in definitive radiochemotherapy of advanced inoperable esophageal cancer. Diseases of the Esophagus. 25(6). 545–554. 15 indexed citations

Stoelben, Erich, Rudolf M. Huber, R.-P. Müller, & J. Wolf. (2010). Multimodale Therapie des Lungenkarzinoms. Der Internist. 51(11). 1348–1357. 3 indexed citations

Neuhaus, T., Y. Ko, R.-P. Müller, et al.. (2009). A phase III trial of topotecan and whole brain radiation therapy for patients with CNS-metastases due to lung cancer. British Journal of Cancer. 100(2). 291–297. 71 indexed citations

Semrau, R., Daniel Vallböhmer, Arnulf H. Hölscher, & R.-P. Müller. (2009). Neoadjuvante Therapie der Adenokarzinome des oberen Gastrointestinaltraktes. Der Chirurg. 80(11). 1035–1041. 5 indexed citations

Anke, M., et al.. (2007). The biological and toxicological importance of molybdenum in the environment and in the nutrition of plants, animals and man. Acta Biologica Hungarica. 58(3). 325–333. 13 indexed citations

10.

Nogová, Lucia, Thorsten Reineke, Hans Theodor Eich, et al.. (2005). Extended field radiotherapy, combined modality treatment or involved field radiotherapy for patients with stage IA lymphocyte-predominant Hodgkin's lymphoma: a retrospective analysis from the German Hodgkin Study Group (GHSG). Annals of Oncology. 16(10). 1683–1687. 84 indexed citations

11.

Treuer, Harald, et al.. (2000). On isocentre adjustment and quality control in linear accelerator based radiosurgery with circular collimators and room lasers. Physics in Medicine and Biology. 45(8). 2331–2342. 47 indexed citations

12.

Treuer, Harald, et al.. (1998). Computerized optimization of multiple isocentres in stereotactic convergent beam irradiation. Physics in Medicine and Biology. 43(1). 49–64. 14 indexed citations

13.

Köcher, Martin, Harald Treuer, & R.-P. Müller. (1997). Quantification of tumor reoxygenation during accelerated radiation therapy.. Radiology. 205(1). 263–268. 9 indexed citations

14.

Voges, Jürgen, Harald Treuer, Ralph Lehrke, et al.. (1997). Risk Analysis of LINAC Radiosurgery in Patients with Arteriovenous Malformation (AVM). PubMed. 68. 118–123. 32 indexed citations

15.

Voges, J., V. Sturm, Harald Treuer, et al.. (1996). LINAC-Radiosurgery (LINAC-RS) in Pituitary Adenomas: Preliminary Results. PubMed. 65. 41–43. 32 indexed citations

16.

Voges, Jürgen, Harald Treuer, Johannes Erdmann, et al.. (1994). Linac Radiosurgery in Brain Metastases. Acta neurochirurgica. Supplementum. 62. 72–76. 32 indexed citations

17.

Bogaert, W. Van den, M. van Glabbeke, M. Piérart, et al.. (1994). Patient population analysis in eortc trial 22881/10882 on the role of a booster dose in breast-conserving therapy. European Journal of Cancer. 30(14). 2073–2081. 22 indexed citations

18.

Müller, R.-P., et al.. (1993). Experimente zum Doppler-Effekt.. 69(6). 313–321. 1 indexed citations

19.

Sturm, V., Wolfgang Schlegel, O. Pastyr, et al.. (1993). Linac-Accelerator-Radiosurgery. PubMed. 58. 89–91. 5 indexed citations

20.

Eble, Michael J., et al.. (1989). The role of radiotherapy in the management of Hodgkin disease in childhood — results of the German association for treatment and research in pediatric leukaemia (DAL). International Journal of Radiation Oncology*Biology*Physics. 17. 137–138. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact